Wu, Jo-HsuanJo-HsuanWuSHENG-NAN CHANGNishida, TakashiTakashiNishidaBO-I KUOJOU-WEI LIN2022-08-092022-08-092022-030721-832Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/616488To evaluate the intraocular pressure (IOP)-reducing efficacy and safety of Rho-kinase inhibitor (RKI).enEfficacy; Glaucoma; Intraocular pressure; Netarsudil; Ocular adverse events; Ocular safety; Rho-kinase inhibitor; RipasudilIntraocular pressure-lowering efficacy and ocular safety of Rho-kinase inhibitor in glaucoma: a meta-analysis and systematic review of prospective randomized trialsjournal article10.1007/s00417-021-05379-7344914272-s2.0-85114489586WOS:000693509000001https://scholars.lib.ntu.edu.tw/handle/123456789/586550